Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125090682 | 12509068 | 2 | F | 20160331 | 20160622 | 20160629 | 20160707 | EXP | FR-FRI-1000085607 | FOREST | 54.89 | YR | M | Y | 0.00000 | 20160707 | OT | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125090682 | 12509068 | 1 | PS | MILNACIPRAN | MILNACIPRAN | 1 | Oral | 100 MG (2 CAPSULES PER DAY) | Y | 22256 | 50 | MG | CAPSULE | BID | |||||
125090682 | 12509068 | 2 | SS | TERCIAN | CYAMEMAZINE | 1 | Oral | 50 MG | 0 | 50 | MG | QD | |||||||
125090682 | 12509068 | 3 | SS | TERCIAN | CYAMEMAZINE | 1 | Oral | 100 MG | 0 | 100 | MG | QD | |||||||
125090682 | 12509068 | 4 | SS | COVERSYL | PERINDOPRIL | 1 | Unknown | 5 MG | 0 | 5 | MG | TABLET | QD | ||||||
125090682 | 12509068 | 5 | SS | SERESTA | OXAZEPAM | 1 | Oral | 95 MG | 0 | TABLET | |||||||||
125090682 | 12509068 | 6 | SS | ATORVASTATINE | ATORVASTATIN | 1 | Oral | 80 MG | 0 | 80 | MG | QD | |||||||
125090682 | 12509068 | 7 | SS | BACLOFEN. | BACLOFEN | 1 | Oral | 200 MG | 0 | 50 | MG | QID | |||||||
125090682 | 12509068 | 8 | SS | KARDEGIC | ASPIRIN LYSINE | 1 | Oral | 75 MG | 0 | 75 | MG | POWDER AND SOLVENT FOR ORAL SOLUTION | QD | ||||||
125090682 | 12509068 | 9 | SS | EFIENT | PRASUGREL HYDROCHLORIDE | 1 | Oral | 10 MG | 0 | 10 | MG | FILM COATED TABLET | QD | ||||||
125090682 | 12509068 | 10 | SS | KREDEX | CARVEDILOL | 1 | Oral | 12.5 MG | 0 | 6.25 | MG | TABLET | BID | ||||||
125090682 | 12509068 | 11 | C | HAVLANE | LOPRAZOLAM | 1 | 0 | ||||||||||||
125090682 | 12509068 | 12 | C | NICOPATCH | NICOTINE | 1 | 0 | ||||||||||||
125090682 | 12509068 | 13 | C | OXAZEPAM. | OXAZEPAM | 1 | 0 | ||||||||||||
125090682 | 12509068 | 14 | C | ZOPLICONE | ZOPICLONE | 1 | 0 | ||||||||||||
125090682 | 12509068 | 15 | C | ANETHOLE TRITHIONE | 2 | 0 | |||||||||||||
125090682 | 12509068 | 16 | C | CARVEDILOL. | CARVEDILOL | 1 | 0 | ||||||||||||
125090682 | 12509068 | 17 | C | UVEDOSE | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
125090682 | 12509068 | 18 | C | PARACETAMOL | ACETAMINOPHEN | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125090682 | 12509068 | 1 | Depression |
125090682 | 12509068 | 2 | Depression |
125090682 | 12509068 | 4 | Hypertension |
125090682 | 12509068 | 5 | Product used for unknown indication |
125090682 | 12509068 | 6 | Product used for unknown indication |
125090682 | 12509068 | 7 | Product used for unknown indication |
125090682 | 12509068 | 8 | Product used for unknown indication |
125090682 | 12509068 | 9 | Product used for unknown indication |
125090682 | 12509068 | 10 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125090682 | 12509068 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125090682 | 12509068 | Headache | |
125090682 | 12509068 | Hyponatraemia | |
125090682 | 12509068 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125090682 | 12509068 | 1 | 20160331 | 0 | ||
125090682 | 12509068 | 2 | 20160313 | 0 | ||
125090682 | 12509068 | 3 | 20160313 | 0 | ||
125090682 | 12509068 | 8 | 201506 | 0 | ||
125090682 | 12509068 | 9 | 201506 | 0 | ||
125090682 | 12509068 | 10 | 201506 | 0 | ||
125090682 | 12509068 | 11 | 20160313 | 0 |